ANTIPODES PARTNERS Ltd

Position in AZN — Astrazeneca PLC

CIK 1652442 ROYAL EXCHANGE, C3

Position in AZN

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$277,982

New position

Shares Held

1,466

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#1,078

of 1,462 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ANTIPODES PARTNERS Ltd holds $183,532,568 across 5 Drug Manufacturers - General names. AZN ranks #4 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	1,097,509	$141,029,906
2	JNJ	Johnson & Johnson	91,816	$23,318,509
3	BIIB	Biogen Inc.	86,827	$18,759,841
4	AZN	Astrazeneca PLC This page	1,466	$277,982
5	LLY	ELI LILLY & Co	122	$146,330

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$277,982	1,466	—	Shares	Sole	2026-08-06
No filing history on record for this holder in this stock.